- Specialization
- Not classified
- Business
- Retail Operations
- Market
Beauty and Personal Careand 1 more market valuesLess
- Healthcare
- Ecosystem
- Not applicable
- Customers
- Consumers
More details
- Organization type
- Commercial Company
- Ecosystem
- Not applicable
- Business
- Retail Operations
- Specialization
- Not classified
- Market
- Beauty and Personal Care, Healthcare
- Customers
- Consumers
- Delivery models
- Physical Goods
- Revenue models
- Product Sales, Subscription
- Listing status
- Not classified
- Latest equity round
- Not classified
- Reported funding amount
- Not classified
About
Soteri Skin is a direct-to-consumer skincare company offering steroid-free, non-prescription topical treatments for chronic skin conditions, especially eczema. Its key differentiator is patented pH/LOCK technology, designed to restore skin acidity and maintain a therapeutic pH for more than 12 hours.
Market
Soteri Skin competes in the direct-to-consumer, over-the-counter eczema and sensitive-skin skincare market. It positions itself as a clinically tested, non-steroidal alternative focused on correcting and stabilizing skin pH for longer-term barrier repair, rather than only providing conventional moisturization or short-term itch relief. Its primary differentiation is the pH/LOCK® system, which Soteri says maintains therapeutic skin pH for 12+ hours, combined with a two-step regimen, postbiotic microbiome support, and a dermatologist-run clinical trial.
Soteri Skin is a D2C/B2C skincare brand for individuals and families managing chronic eczema, recurring flare-ups, or sensitive and eczema-prone skin. Its key buyer personas include parents of infants and toddlers, consumers aged 5+, and people seeking steroid-free, non-prescription long-term relief; company size is not applicable because the product is sold to end consumers rather than enterprises.
At a Glance
Problem
SOTERI SKIN addresses eczema, a chronic skin condition that can cause recurring irritation and require ongoing care across babies, children, and adults. The core pain is not a one-time flare but the need for dependable, affordable relief and a routine that helps people manage symptoms over time. Its main use case is everyday eczema care for consumers seeking an alternative to steroid-based products and ordinary moisturizers.
The company emphasizes affordability through subscription pricing, suggesting an economics centered on repeat purchases rather than occasional treatment. Its Eczema Relief Kit is listed at $49.99, giving customers a packaged entry point for managing recurring symptoms.
Product / Service
SOTERI SKIN sells steroid-free over-the-counter medications and skincare products for people with eczema, including an Eczema Relief Kit. The company’s delivery model combines direct-to-consumer product sales with affordable subscriptions, allowing customers to replenish products as part of an ongoing skincare regimen.
Its differentiating technology is pH/LOCK®, described as a patented system that restores skin to an ideal pH of 4.7 and keeps it balanced for up to 12 hours. The intended benefit is more durable skin-barrier support than a conventional moisturizer alone, while providing a clinically positioned, dermatologist-approved alternative for eczema relief.
Market
SOTERI SKIN competes in consumer skin health and eczema care, overlapping with beauty-care products for chronic skin conditions, OTC eczema treatments, steroid-based medications, and traditional moisturizers. The evidence does not identify specific named competitors; its positioning is instead differentiated around steroid-free care, clinical testing, dermatologist approval, pH-balancing technology, and subscription access.
The company appears to be an early but post-revenue startup rather than pre-revenue. It was founded in 2021, participated in Y Combinator’s Winter 2022 program, and is reported as having approximately $1.9 million in revenue. Its website shows an Eczema Relief Kit with 197 reviews, while a YC profile lists a very small team of two employees, indicating initial customer traction but an early operating scale.
Founders & Leadership
Funding History
Y Combinator
Recent News
The National Eczema Association published a product-directory page for Soteri Skin Long-Term Relief Cream. The page describes it as a pH/LOCK®-powered moisturizer for eczema-prone and chronically dry skin that supports the skin barrier and natural acid mantle.
A DailyMed label record dated October 23, 2025 covers Soteri Skin Baby Eczema Relief Cream, an OTC skin protectant intended to temporarily protect against and relieve minor irritation and itching associated with eczema. The label instructs users to apply it twice daily.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Soteri Skin sells over-the-counter eczema creams and treatment kits through a direct-to-consumer e-commerce storefront, generating revenue from product purchases. It also offers recurring subscriptions at a 15% discount to encourage consistent use.